Profil

CROMBEZ Deborah


Main Research Fields
Immunology & infectious disease
Endocrinology, metabolism & nutrition
Pharmacy, pharmacology & toxicology
Zoology
Biotechnology
Main Keywords
AMPK; diabetes; peptides; phage display; therapy;
Main Unit & Research Centers
CMMI - Centre de Recherche en Microscopie et Imagerie Médicale
Main Co-authors
Burtea, Carmen 
Muller, Robert 
Scaux, Géraldine
Vander Elst, Luce 

Publications (total 14)

The most downloaded
3 downloads
Stanicki, D., Boutry, S., Laurent, S., Wacheul, L., Nicolas, E., Crombez, D., Vander Elst, L., Lafontaine, D., & Muller, R. (03 March 2014). Carboxy-silane coated iron oxide nanoparticles: a convenient platform for cellular and small animal imaging. Journal of Materials Chemistry B, 2 (4), 387-397. https://hdl.handle.net/20.500.12907/38055
The most cited
31 citations (Scopus®)
Stanicki, D., Boutry, S., Laurent, S., Wacheul, L., Nicolas, E., Crombez, D., Vander Elst, L., Lafontaine, D., & Muller, R. (03 March 2014). Carboxy-silane coated iron oxide nanoparticles: a convenient platform for cellular and small animal imaging. Journal of Materials Chemistry B, 2 (4), 387-397. https://hdl.handle.net/20.500.12907/38055

Crombez, D., Vander Elst, L., Muller, R., & Burtea, C. (18 May 2016). Nouvelle stratégie thérapeutique du diabète de type 2 : activation de la voie AMPK via un agoniste peptidique des récepteurs de l'adiponectine. Poster session presented at 9ème édition de la Matinée des Chercheurs 2016 (MdC2016), Valenciennes, France.

Crombez, D., Muller, R., & Burtea, C. (04 May 2016). Potential therapeutic peptides targeted to adiponectin receptors, able to modulate the AMPK pathway and regulate the glucose and lipid metabolism. Paper presented at Diabetes Kongress, Berlin, Germany.

Crombez, D., Muller, R., & Burtea, C. (04 May 2016). Potential therapeutic peptides targeted to adiponectin receptors, able to modulate the AMPK pathway and regulate the glucose and lipid metabolism. Poster session presented at Diabetes Kongress, Berlin, Germany.

Crombez, D., Muller, R., & Burtea, C. (17 February 2016). Type 2 diabetes and metabolic syndrome : agonist peptides targeted to adiponectin receptors are new therapeutic strategy by activation of AMPK pathway. Poster session presented at Belgian Peptide Group Meeting, Bruxelles, Belgium.

Ansciaux, E., Burtea, C., Laurent, S., Crombez, D., Nonclercq, D., Vander Elst, L., & Muller, R. (05 June 2015). In vitro and in vivo characterization of several functionalized USPIO vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Contrast Media and Molecular Imaging, 10 (3), 211-224. doi:10.1002/CMMI.1626
Peer Reviewed verified by ORBi

Crombez, D., Scaux, G., Muller, R., & Burtea, C. (22 May 2015). A metabolic therapy of Type 2 Diabetes : AMPK activation by agonist peptides targeted to adiponectin receptors. Poster session presented at Journée d'études UMHAP - from lab to bedside, UMONS, Belgium.

Crombez, D., Scaux, G., Muller, R., & Burtea, C. (13 May 2015). A metabolic therapy of Type 2 Diabetes : AMPK activation by agonist peptides targeted to adiponectin receptors. Poster session presented at Bioforum 2015- ULG, Liège, Belgium.

Crombez, D., Scaux, G., Muller, R., & Burtea, C. (10 March 2015). Development of an Adiponectin Receptor Agonist for the Metabolic Therapy of Type 2 Diabetes. Poster session presented at 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium.

Burtea, C., Laurent, S., Crombez, D., Delcambre, S., Sermeus, C., Millard, I., Rorive, S., Flamez, D., Beckers, M.-C., Salmon, I., Vander Elst, L., Eizirik, D., & Muller, R. (18 February 2015). Development of a peptide-functionalized imaging nanoprobe for the targeting of (FXYD2)gamma-a as a highly specific biomarker of pancreatic beta cells. Contrast Media and Molecular Imaging, 10 (5), 398-412. doi:10.1002/cmmi.1641
Peer Reviewed verified by ORBi

Crombez, D., Laurent, S., Scaux, G., Vander Elst, L., Muller, R., & Burtea, C. (16 January 2015). Development of a molecular approach for the monitoring and treatment of diabetic patients. Poster session presented at 7th annual meeting ISMRM Benelux, Ghent, Belgium.

Crombez, D., Scaux, G., Muller, R., & Burtea, C. (18 November 2014). Thérapie métabolique des troubles liés au diabète de type 2 via le développement d'un agoniste du récepteur de l'adiponectine. Poster session presented at Biomarqueurs d'imagerie du métabolisme et du risque cardio-vasculaire, Lyon, France.

Stanicki, D., Boutry, S., Laurent, S., Wacheul, L., Nicolas, E., Crombez, D., Vander Elst, L., Lafontaine, D., & Muller, R. (03 March 2014). Carboxy-silane coated iron oxide nanoparticles: a convenient platform for cellular and small animal imaging. Journal of Materials Chemistry B, 2 (4), 387-397.
Peer reviewed

Crombez, D., Delcambre, S., Muller, R., & Burtea, C. (10 February 2014). Development of a peptide agonist of adiponectin receptor for the therapy of type 2 diabetes and metabolic syndrome. Poster session presented at Belgian Peptide Meeting, Ghent, Belgium.

Crombez, D., Burtea, C., & Muller, R. (24 May 2013). Therapy of type 2 diabetes: development of an agonist of adiponectin receptor. Poster session presented at 1st Health Institute Day, Mons, Belgium.

Contact ORBi